or Try an Advanced Search...

    Cardiovascular And Other Diseases Stocks List

    Symbol Grade Name % Change
    ITCI A Intra-Cellular Therapies Inc. 2.11
    LNTH C Lantheus Holdings, Inc. -1.69
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Medicine Aging Associated Diseases Alzheimer's Disease Artery Artery Disease Autism Autism Spectrum Disorder Biopharmaceutical Bipolar Disorder Chemical Elements Cognitive Disorders Cognitive Dysfunction Cognitive Impairment Congestive Heart Failure Coronary Artery Disease Dementia Depressive Disorder Disease Disorders Drug Development

    Related ETFs - A few ETFs which own one or more of the above listed Cardiovascular And Other Diseases stocks.

    Symbol Grade Name Weight
    MEDI D Harbor Health Care ETF 5.65
    GRPM C Invesco S&P MidCap 400? GARP ETF 4.12
    PSIL B AdvisorShares Psychedelics ETF 3.89
    IBRN B iShares Neuroscience and Healthcare ETF 3.71
    XPH B SPDR S&P Pharmaceuticals ETF 3.49
    View all Cardiovascular And Other Diseases ETFs...
    Compare ETFs
    Compare MEDI to IBRN Compare MEDI to XPH Compare PSIL to XPH

        Cardiovascular And Other Diseases Stocks Recent News

        Date Stock Title
        Nov 2 ITCI Here's What Analysts Are Forecasting For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) After Its Third-Quarter Results
        Nov 1 LNTH Jim Cramer Likes Cava Group, Calls This Utilities Stock 'Terrific'
        Nov 1 ITCI Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Nov 1 LNTH Lantheus Holdings (LNTH) Achieves 22.5% Revenue Growth in Q2 2024
        Oct 31 ITCI Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...
        Oct 30 ITCI Intra-Cellular Therapies, Inc. (ITCI) Q3 2024 Earnings Call Transcript
        Oct 30 ITCI Intra-Cellular jumps on Q3 beat as Caplyta outlook brightens
        Oct 30 ITCI ITCI Q3 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales
        Oct 30 ITCI Intra-Cellular Therapies (ITCI) Reports Q3 Loss, Tops Revenue Estimates
        Oct 30 ITCI Intra-Cellular: Q3 Earnings Snapshot
        Oct 30 ITCI Intra-Cellular Therapies GAAP EPS of -$0.25 misses by $0.04, revenue of $175.4M beats by $3.05M
        Oct 30 ITCI Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
        Oct 29 ITCI Intra-Cellular Therapies Q3 2024 Earnings Preview
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Medicine Aging Associated Diseases Alzheimer's Disease Artery Artery Disease Autism Autism Spectrum Disorder Biopharmaceutical Bipolar Disorder Chemical Elements Cognitive Disorders Cognitive Dysfunction Cognitive Impairment Congestive Heart Failure Coronary Artery Disease Dementia Depressive Disorder Disease Disorders Drug Development
        Cardiovascular And Other Diseases

        Cardiovascular and other diseases are a group of conditions that affect the heart and blood vessels. These diseases include coronary artery disease, stroke, heart failure, arrhythmia, and congenital heart defects. Other diseases include high blood pressure, diabetes, and obesity. These diseases can lead to serious health complications, including heart attack, stroke, and death.

        Browse All Tags